Former Boston Scientific Executive Joins Ceryx Medical’s Board

robot
Generación de resúmenes en curso

Ceryx Medical has appointed Mark Strong, a former executive from Boston Scientific and Abbott, as a non-executive board director. This strategic move aims to strengthen Ceryx Medical’s position in the cardiac rhythm management (CRM) market by leveraging Strong’s extensive experience in product development, commercialization, and regulatory navigation. His expertise is expected to guide the company’s growth, enhance product offerings, and expand market reach in the evolving CRM sector.

Esta página puede contener contenido de terceros, que se proporciona únicamente con fines informativos (sin garantías ni declaraciones) y no debe considerarse como un respaldo por parte de Gate a las opiniones expresadas ni como asesoramiento financiero o profesional. Consulte el Descargo de responsabilidad para obtener más detalles.
  • Recompensa
  • Comentar
  • Republicar
  • Compartir
Comentar
Añadir un comentario
Añadir un comentario
Sin comentarios
  • Anclado